NILA Submits Comments in Response to CMS’ RFI Regarding CLIA Revisions

NILA submitted comments in response to CMS’ Request for Information regarding revisions to CLIA's Personnel Regulations; Sanctions for referring Proficiency Testing specimens; Histocompatibility Regulations; and Fees. View NILA’s comments (PDF ).

NILA News

5/24/2024
FDA Publishes Proposed Enforcement Policies for Tests During a Declared Emergency

5/6/2024
Final Rule on LDTs officially published in Federal Register

4/29/2024
NILA and American Association of Bioanalysts (AAB) Respond to FDA's Release of Final Rule on LDTs

Laboratory Outreach Communications System (LOCS)

Click here for laboratory-related information and communications from the Centers for Disease Control and Prevention (CDC).